SCHEMBL20735973

SCHEMBL20735973

CCCc1nc2ccccc2n1-c1cccc(-c2cc3c(c4ccccc24)-c2ccc4ccccc4c2C32c3ccccc3-c3ccccc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
PDE10A Q9Y233 4/20 0.37
CYP1A2 P05177 2/20 0.37
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
PPARG P37231 3/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 1/20 0.32
NTRK1 P04629 1/20 0.31
NTRK2 Q16620 1/20 0.31
GAA P10253 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737153 0.92 CYP1A2 (0.38) USP2PDE10ACYP1A2CNR1CNR2
SCHEMBL27250516 0.91 USP2 (0.39) USP2PDE10ACYP1A2CNR1CNR2
SCHEMBL27250576 0.89 PDE10A (0.37) USP2PDE10ACYP1A2CNR1CNR2
SCHEMBL20736540 0.89 USP2 (0.41) USP2PDE10ACYP1A2CNR1CNR2
SCHEMBL27250390 0.89 USP2 (0.40) USP2PDE10ACYP1A2PPARGPOLB
SCHEMBL20737120 0.86 PDE10A (0.40) USP2PDE10ACYP1A2CNR1CNR2
SCHEMBL20735890 0.85 USP2 (0.40) USP2PDE10ACYP1A2PPARGPOLB
SCHEMBL20737162 0.85 PDE10A (0.36) PDE10ACYP1A2CNR1CNR2MEN1
SCHEMBL20735972 0.85 ESR1 (0.39) PDE10APOLBMEN1KMT2AMAPT
SCHEMBL20737305 0.85 USP2 (0.39) USP2PDE10ACYP1A2CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 USP2 4455/4885PDE10A 4099/4885CYP1A2 739/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 USP2 4455/4885PDE10A 4099/4885CYP1A2 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.